Year-over-year earnings per share growth for the last twelve months: Fulgent Genetics, Inc. (FLGT)
Fulgent Genetics, Inc. (FLGT) generates revenue from complex genetic testing and reproductive health orders. The quarterly earnings per share shift on GURU.Markets captures the business's resilience, where -121.50 reflects the latest metric level. Fulgent Genetics, Inc. (FLGT) relies on a B2B cloud platform featuring an extensive range of oncology panels and is currently scaling the implementation of AI in data analysis.
Financial and market metric breakdowns for Fulgent Genetics, Inc. (FLGT)
- share price and expert price forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Debt to Equity Fulgent Genetics, Inc.|FLGT - Long-Term Debt to Equity|Short-Term Debt to Capital fulgentgenetics.com|FLGT - Company Total Indebtedness|Debts to Book Capitalization Fulgent Corp|FLGT - Long-Term Debt|Company Short-Term Debt Fulgent Genetics|Quick Liquidity Indicator fulgentgenetics.com
- earnings and valuation multiples indicators:
FLGT - Profit After Payment of Taxes|Future Profit Fulgent Genetics, Inc.|FLGT - Company Value to Net Income|Forward P/E Multiple Fulgent|FLGT - Price to Net Income Growth Ratio|EV/EBITDA Multiple Fulgent Corp|FLGT - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Fulgent Genetics|FLGT - Earnings per share for the last 12 months|Quarterly EPS earnings growth fulgentgenetics.com|FLGT - Earnings per share growth rate in current year|Expected earnings per share growth for next year Fulgent Genetics, Inc.
- issuer revenue and sales details:
Fundamental company analysis:fulgentgenetics.com - FLGT
A comparative asset analysis requires precise measurement of net income per share dynamics. The calculation model updates quarterly EPS growth rates daily, eliminating information gaps between financial reports. This is critical for Fulgent Genetics, Inc. (FLGT) due to declining demand for genetic tests and pricing pressure in oncology diagnostics. The downward trend confirms the risk of business stagnation. By analyzing quarterly EPS fluctuations, an investor can timely identify the threat of a deep price drawdown.
Analysis of competing companies
A: Quarterly EPS earnings growth|DGX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months illumina.com|Exact Sciences (EXAS) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Revvity (RVTY)|Year-over-year net earnings per share change for the last twelve months Bio-Rad Laboratories, Inc.|Year-over-year earnings per share growth for the last twelve months Anbio Biotechnology NNNN|Year-over-year earnings per share growth rate for the last twelve months SHC (Sterigenics)|quidel.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months OPKO Health|CDNA: Quarterly EPS earnings growth|Maravai LifeSciences Corp (MRVI) - Quarterly EPS earnings growth|LAB (Standard BioTools Inc) - Quarterly EPS earnings growth|Quarterly EPS earnings growth Cytek Biosciences, Inc.|Year-over-year earnings per share growth for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months MDxHealth MDXH|LUCD: Year-over-year earnings per share growth for the last 12 months|PRE - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months IMDX (Insight Molecular Diagnostics Inc)|TRIB: Quarterly EPS earnings growth|prophaselabs.com - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months HSCS (Heart Test Laboratories Inc.)|Year-over-year net earnings per share change for the last twelve months Biomerica Inc|Year-over-year earnings per share growth for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Year-over-year earnings per share growth for the last 12 months|VRAX - Year-over-year earnings per share growth for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Year-over-year earnings per share growth for the last 12 months|AWH: Quarterly EPS earnings growth|Accelerate Diagnostics, Inc (AXDX) - Quarterly EPS earnings growth|CNTG (CENTOGENE, N.V.) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Enzo Biochem (ENZ)|Year-over-year net earnings per share growth for the last 12 months FRES (fresh2.co)|GENE - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months 23andMe Inc ME|PMD: Year-over-year earnings per share growth for the last 12 months
